Photo of Emily N. Israel
Emily N. Israel
Clinical Associate Professor of Pharmacy Practice
Phone: 317-880-5409
E-mail: israele@purdue.edu
Education
2014 Pediatric Pharmacy Residency, University of Michigan Health System 2013 Pharmacy Practice Residency, University of Michigan Health System 2012 PharmD, University of Iowa 2008 BSc, Marine Sciences and Spanish, Rutgers University
Research
Interests

Pharmacy education, drug therapy in congenital heart disease

Service and Engagement

Riley Pediatric Pharmacy Intership Co-Coordinator

Teaching

PHRM 825, Integrated Pharmacotherapy I

PHRM 844, Integrated Pharmacotherapy III

PHRM 860, 861, Pharmacy Skills Laboratory

PHRM 864, Integrated Pharmacotherapy IV

PHRM 880, Purdue APPE Rotation

CLPH 435, Pediatric Pharmacotherapy

Indiana University Health Residency Rotations - Pediatric Cardiology

Honors and Credentials

Scholarship of Engagement Fellow - Purdue University Office of Engagement (2019)

Mariner Project Exchange Program - Medical University of South Carolina (2018)

Teach for Tomorrow Junior Faculty Fellowship - Purdue University Center for Instructional Excellence (2017)

Board Certified Pediatric Pharmacy Specialist (2015 - present)

Board Certified Pharmacotherapy Specialist (2013 - present)

Clinical Practice

Clinical Pharmacy Specialist, Pediatric Cardiology - Riley Hospital for Children at Indiana University Health, Indianapolis, IN

Representative Publications

1. Israel EN, Isaacs AN. Fundamentals of Precepting. In: Lee BR, Ohler KH, eds. Pediatric Self-Assessment Program, 2022 Book 2. Preventative Care, Public Health, and Preceptorship.

2. Shockley AN, Israel EN, Thomas CA. Risk of mistimed live vaccination after pediatric cardiovascular surgery. J Pediatr Pharmacol Ther. 2022;27(8):750-753.

3. Israel EN, Smith IA. Five-year review of a pediatric pharmacy internship program. J Pediatr Pharmacol Ther. 2022;27(8):690-694.

4. Drwiega EN, Nichols KR, Israel EN, Knoderer CA. Impact of rapid mecA polymerase chain reaction rapid diagnostic testing for Staphylococcus aureus in a pediatric setting. Infect Dis Clin Pract. 2019; 27(5):268-72.

5. Bednarz AM, Israel EN, Beckman EJ, Johansen M, Thomas CA. Safety of enteral sildenafil in hemodynamically unstable children. Cardiol Young. 2019; 29(5): 589-93.

6. Israel EN, Thomas CA, Mastropietro CM. Establishment of prophylactic enoxaparin dosing recommendations to achieve targeted anti-factor Xa concentrations in children with CHD. Cardiol Young. 2018; 28(5): 715-8.

7.  Nichols KR, Israel EN, Thomas CA, Knoderer CA. Optimizing guideline-recommended antibiotic doses for pediatric infective endocarditis. Ann Pharmacotherapy. 2016; 50(5):423-27.

8. Israel EN, Blackmer A. Use of tissue plasminogen activator to treat parapneumonic effusion in pediatric patients. Pharmacotherapy. 2014; 34(5):521-32.

9. Israel EN, Farley TM, Carter BL. Analysis of a pharmacist-led continuity of care service on underutilization of cardiovascular medications. Am J Health Syst Pharm. 2013;70:1592-1600.